ELI LILLY & Co is 2.7x more valuable than AbbVie Inc. by market capitalization ($1.072 T vs $399.47 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ABBV | LLY |
|---|---|---|
| Market cap | $399.47 B | $1.072 T |
| US-listed rank | #28 | #10 |
| Revenue (latest FY) | $61.16B | $65.18B |
| Net income (latest FY) | $4.23B | $20.64B |
| Net margin | 6.9% | 31.7% |
| P/E (trailing FY) | 94.5 | 51.9 |
| SEC filings | 1,008 | 989 |
ELI LILLY & Co is 2.7x more valuable than AbbVie Inc. by market capitalization ($1.072 T vs $399.47 B).
In their latest fiscal years, AbbVie Inc. reported $61.16B in revenue while ELI LILLY & Co reported $65.18B.
Full pages: AbbVie Inc. and ELI LILLY & Co, or browse the full rankings.